Replikins announced its latest findings regarding the virus replikin count in human H5N1 influenza virus. The company's software-driven analysis has found that the prevalence of these sequences has remained high in Indonesia; in addition, higher counts now have been found in China. These statistics reflect an "upregulation" of this gene which has been linked to the lethality of influenza viruses.
Ads by Google
Flu and Cold
Merck announces voluntary vaccine recall of certain lots of PEDVAXHIB and COMVAX. Merck vaccine recall is due to the fact that the company cannot assure sterility of these specific vaccine lots.
GE Healthcare announced a collaboration agreement to develop and market a pandemic influenza vaccine manufacturing solution for selected international countries. This collaboration leverages GE Healthcare's bioprocess solutions and design expertise and Novavax's virus- like particle (VLP) and manufacturing platform.
For families with young children, cold and flu season is an endless cycle of somebody getting sick, recovering and then catching the next round from another family member or friend. Add to the mix the latest FDA concerns about cold and cough medicine safety for kids, and the drill becomes even more complicated.
As cold and flu season hits this year amid growing debate over the necessity of vaccinations, University of Toronto researchers have uncovered widespread misinformation in related videos on YouTube.
Florida Department of Health recognizes November 27 as Children's Flu Vaccination Day and reminds Floridians that the week after Thanksgiving, November 26 to December 2, is National Influenza Vaccination Week.
Minnesota has recorded its first culture-confirmed case of influenza for the 2007-08 season in a 44-year-old woman from Dakota County. The woman's illness was caused by the B/Shanghai-like strain of the virus, the Minnesota Department of Health reported today. The woman's virus is a good match for this year's vaccine, health officials said. The specimen was submitted by the University of Minnesota Medical Center, Fairview.
AlphaVax has concluded a phase 1 clinical trial in 216 volunteers of an influenza vaccine based on its proprietary replicon vector platform.
Experts to increase their projections of how many pandemic influenza vaccine courses can be made available in the coming years.
Bayer Consumer Care announces the availability of the newly-named ALEVE-D Sinus and Cold.
The Childhood Influenza Immunization Coalition has launched a Web site to support its newly issued report that calls for improved childhood influenza immunization rates in the United States.
State health officials are encouraging people who are at high risk for developing complications from influenza to get the influenza vaccine before the coming winter season. Individuals who are considered to be at high risk are children age six months through five years of age, people age 50 and older, and individuals with chronic medical conditions or compromised immune systems.
Health Protection Agency resumes its winter monitoring of flu activity in the UK. The flu season runs from October to May and, depending on the level of flu across the UK, an update will be published on the Agency's website either weekly or fortnightly.
The aim is to provide a comprehensive overview of the current situation in relation to flu including:
The influenza A virus does not lie dormant during summer but migrates globally and mixes with other viral strains before returning to the Northern Hemisphere as a genetically different virus, according to biologists who say the finding settles a key debate on what the virus does during the summer off-season when it is not infecting people.
Alabama Influenza immunization clinics are scheduled throughout the state beginning in October through the end of the influenza season.